OrthoAccel Technologies Receives $5,000,000 New Financing Round

  • Feed Type
  • Date
    12/23/2014
  • Company Name
    OrthoAccel Technologies
  • Mailing Address
    6575 West Loop South Bellaire, TX 77401 USA
  • Company Description
    The AcceleDent System is currently in a randomized controlled clinical trial at the University of Texas Health Science Center in San Antonio. This trial was enrolled under an Investigational Device Exemption.
  • Website
    http://www.orthoaccel.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy